Libido, Tanning, Sleep & Niche — Category Comparisons
Published · Researched 2026-09-21
Category Comparisons — Libido, Tanning, Sleep & Niche
Track: 13 items · Research date: 2026-09-20 · Report index at bottom
This file compares the 13 items in the Libido, Tanning, Sleep & Niche track head-to-head. All prices observed 2026-09-20 (grey-market research-peptide listings unless noted). Tiers: Tier 1 = independent evidence across Facebook groups + Instagram + Threads; Tier 2 = genuine social signal on at least two layers but missing the Facebook-group pillar or heavily ad-skewed; Tier 3 = vendor-catalog existence only, no verified organic owner discussion.
Specs head-to-head
| Item | Class / size | Target | Standard grey-market presentation | Half-life note |
|---|---|---|---|---|
| PT-141 (Bremelanotide) | Cyclic heptapeptide, ~1025 Da | MC4R (central) | 10 mg vial | ~2.7 h SC (approved-product data) |
| Kisspeptin-10 | Decapeptide, ~1302 Da | KISS1R → GnRH | 5 mg vial | Minutes-scale — UNVERIFIED |
| Melanotan I (Afamelanotide) | Linear tridecapeptide, ~1647 Da | MC1R-skewed | 10 mg vial | Longer than α-MSH by design — UNVERIFIED |
| Melanotan II | Cyclic heptapeptide, ~1024 Da | MC1R/MC3R/MC4R/MC5R | 10 mg vial | ~33 h (vendor/community claim) — UNVERIFIED |
| Melanotan II nasal spray | Same peptide, finished spray | Same as MT-II | 10–20 mg bottles | Nasal bioavailability — UNVERIFIED |
| Oxytocin | Nonapeptide, ~1007 Da | OXTR | 2 mg vial / premixed sprays | Minutes-scale IV; intranasal — UNVERIFIED |
| Desmopressin | Nonapeptide analogue | V2 receptor | Pharma tablets/nasal/spray | See dossier |
| DSIP | Nonapeptide | Unknown/putative | 5–15 mg vials | UNVERIFIED |
| Gonadorelin | Decapeptide (native GnRH) | GnRH receptor | 2 mg vial | 2–10 min (vendor-listed) — UNVERIFIED vs primary |
| Triptorelin | Decapeptide ([D-Trp6]-GnRH) | GnRH receptor (desensitizing) | 2 mg vial | Long-acting by design — UNVERIFIED for bolus use |
| Epithalon | Tetrapeptide, ~390 Da | Telomerase/cell-cycle models | 10 mg vial | UNVERIFIED |
| Pinealon | Tripeptide, ~418 Da | Neuronal/oxidative-stress models | 10 mg vial | UNVERIFIED |
| HCG | Glycoprotein, 237 aa | LH receptor | 5000 IU vial | ~24–36 h (vendor-listed) |
Structural note: The track spans the full size range — 3-amino-acid Pinealon to 237-amino-acid HCG. The melanocortin trio (PT-141, MT-I, MT-II) share one discovery program; the GnRH trio (kisspeptin-10 upstream, gonadorelin native, triptorelin desensitizing analogue) share one axis with opposite pharmacology.
Value-for-money (street pricing, single-unit)
| Item | Observed street range | Unit economics note |
|---|---|---|
| PT-141 | ~$30–$50 / 10 mg vial | Branded Vyleesi ~10–20× more per use — UNVERIFIED current Rx pricing |
| Kisspeptin-10 | ~$33–$75 / 5 mg vial | Wide vendor-tier spread |
| Melanotan I | ~$27–$49 / 10 mg vial | Commoditized |
| Melanotan II | ~$40–$45 / 10 mg vial | Tightest pricing in track — most commoditized |
| Melanotan II nasal spray | ~€55–€69 / £55–£56 / ~$79 | Premium over vials; half of listings out of stock |
| Oxytocin | ~$18–$50 / 2 mg vial; sprays $40–$150 | Cheapest vial entry ($18); sprays premium |
| Desmopressin | GoodRx coupon ~$34.50; retail avg $346.98; CanadaDrugsOnline $159.99–$202.01/90 tabs | Pharma-channel item, distinct economics |
| DSIP | $35–$125 / vial (5–15 mg) | Wide range, thin market |
| Gonadorelin | Among the cheapest peptides per vial | |
| Triptorelin | Cheap vial, extreme lore-to-price ratio | |
| Epithalon | Cheap, commoditized | |
| Pinealon | ~$35–$69 / 10 mg vial | Widest spread — thin competition |
| HCG | ~$34–$96 / 5000 IU vial | Wide split: grey vs. pharma-adjacent vendors; Rx channel >$1000 uninsured per forum report |
Value takeaway: Price says little about value here. The cheapest items (gonadorelin, epithalon, MT-II) include both the most commoditized (MT-II) and the least evidenced (epithalon, pinealon). The most expensive (HCG at the top end, oxytocin sprays) reflect pharma-adjacent or finished-format premiums. MT-II nasal spray is the worst unit economics in the track for the same nominal peptide.
Social sentiment matrix
| Item | Tier | Positive pole | Negative pole | Dominant platform |
|---|---|---|---|---|
| PT-141 | Tier 1 | "Acts on desire itself"; works both sexes | Nausea #1 complaint; flushing; batch inconsistency | Facebook groups + Instagram |
| Kisspeptin-10 | Tier 2 | Upstream mechanism; women's-libido pairing frame | Short half-life skepticism; influencer-hype skew | |
| Melanotan I | Tier 3 | "Cleaner" than MT-II (thin evidence) | Drowned out by MT-II confusion; catalog-only presence | None (vendor catalogs) |
| Melanotan II | Tier 2 | Tans reliably; libido side benefit | Mole changes; nausea; polarized safety war | |
| MT-II nasal spray | Tier 3 | Needle-free | Stock-outs; bioavailability doubt; no owner voices | None (vendor catalogs) |
| Oxytocin | Tier 2 | "Sexmaxxing" trend; PT-141 pairing narrative | Clinic-marketing skew; thin owner reporting | |
| Desmopressin | Tier 3 | Pharma legitimacy (distinct channel) | Zero peptide-community signal | Facebook (shortage news) |
| DSIP | Tier 3 (weak) | Sleep-curiosity niche | No human data; thin everything | Threads + forums |
| Gonadorelin | Tier 3 | "Physiological" TRT-adjacent framing | Pulsatile nuance misunderstood; clinic-marketing skew | Instagram (clinic content) |
| Triptorelin | Tier 3 | "Two-shot PCT" lore | Lore without evidence; suppression risk underplayed | None (vendor copy) |
| Epithalon | Tier 3 | Telomerase story; Khavinson lineage | Human outcomes absent; meme > medicine | None (longevity culture) |
| Pinealon | Tier 3 | Neuroprotection narrative | Ghost item — no community at all | None |
| HCG | Tier 2 | TRT-fertility consensus; semen-data grounded | Rx cost; individual variability; fake-product lore | TRT forums (ExcelMale) |
Pattern: Only one Tier 1 (PT-141), four Tier 2 (kisspeptin-10, MT-II, oxytocin, HCG), eight Tier 3. This is the lowest-validated track in the project so far — and the honest headline. The Tier 2s split into trend-driven (kisspeptin, oxytocin, MT-II) vs. forum-grounded (HCG, the most substantive of the four).
Use-case fit & risk matrix
| Use case the community discusses | Best-evidenced item | Key risk flag |
|---|---|---|
| Libido / desire | PT-141 (Tier 1) | Nausea/flushing; grey vials ≠ Vyleesi |
| Tanning | Melanotan II (Tier 2) | Mole/melanocytic changes — the substantive worry |
| Needle-free tanning | MT-II nasal spray (Tier 3) | May not be purchasable; efficacy doubted |
| "Gentler" tanning | Melanotan I (Tier 3) | Name confusion with MT-II; no community base |
| Bonding / mood (trend) | Oxytocin (Tier 2) | Marketing-heavy; spray quality unverifiable |
| Sleep | DSIP (Tier 3 weak) | No human data; weakest evidence in track |
| TRT fertility preservation | HCG (Tier 2) | Rx cost gap; self-dosing without labs |
| HPG-axis "restart" | Gonadorelin / Triptorelin (Tier 3) | Axis suppression risk — the mechanism can invert intent |
| Longevity / telomeres | Epithalon (Tier 3) | Mechanism story without human outcomes |
| Neuroprotection / cognition | Pinealon (Tier 3) | No community; no replication base |
| Nighttime urinary frequency (pharma) | Desmopressin (Tier 3) | Pharma item; grey-market forms separate |
Risk concentration: The GnRH-axis items (gonadorelin, triptorelin) carry the most mechanistic risk — misunderstanding pulsatile vs. continuous exposure produces the opposite hormonal outcome. The tanning items carry the most dermatological risk (moles). The libido items carry the most tolerability risk (nausea).
Headline takeaways
- PT-141 stands alone at Tier 1 — the only item with Facebook-group dosing culture, Instagram owner content, and Threads presence. Everything else in "libido" is trend or lore.
- Melanotan II is the most visible and most polarized — viral physician warnings vs. long-term user defense, with mole changes as the one concern both sides acknowledge.
- HCG is the most substantive Tier 2 — semen-analysis-grounded TRT forum discussion beats influencer trends for evidence quality; it's also the only item with a real prescription path disciplining the conversation.
- The MT-I/MT-II confusion is a finding, not a footnote — most "melanotan" sentiment cannot be attributed to a specific compound.
- Eight of thirteen items are Tier 3 — vendor-catalog existence with no verified organic owner discussion. The Khavinson bioregulators (epithalon, pinealon), the GnRH pair (gonadorelin, triptorelin), MT-I, MT-II nasal spray, desmopressin, and DSIP all live here.
- Nasal-spray formats are the track's weak point — premium pricing, frequent stock-outs, community bioavailability skepticism, and (for oxytocin) unverifiable spray quality.
- The pharma shadow matters — five items (PT-141/Vyleesi, MT-I/Scenesse, oxytocin/Pitocin, desmopressin, HCG/Pregnyl, triptorelin/Trelstar) have approved pharmaceutical siblings whose legitimacy does not transfer to grey-market vials. Every file states this explicitly.
Social-pulse summary
- Platforms searched: Threads, Facebook (incl. 6 groups with observed membership counts: Peptides – information. Education. and sharing (1,000); Peptide Community 101 (878); Biohacking, Longevity, CRISPR, Supplements, Life Extension, Wim Hof (10,000); TRT – Testosterone Replacement Therapy – Wellness Group! (1,000); TanToday Discussion Board and Information (2,000); Tanning tips and facts (4,000)), Instagram, cross-platform social search, TRT/fertility forums (ExcelMale), vendor pages, browser web search.
- Marketplace searches: Performed for PT-141, desmopressin, DSIP (zero listings observed); not performed for the remaining ten items in this pass — used-value data marked UNVERIFIED rather than invented.
- Strongest organic signals: PT-141 Facebook-group dosing thread (Over50BodybuildingFitness, July 2026); HCG ExcelMale fertility threads (multi-year); MT-II Instagram debate (Saladino/Idriss, June 2026).
- Weakest signals: Pinealon (none found anywhere); MT-II nasal spray (no owner discussion despite format hype); triptorelin (lore without owners).
- Contamination notes: Sponsored "protocol update" content with vendor discount codes (MT-II, PT-141 nasal); clinic lead-generation content (gonadorelin, oxytocin, HCG); comment-section vendor spam (PT-141); coordinated influencer trend pushes (kisspeptin, oxytocin "sexmaxxing"). All flagged on the dossier pages, not counted as organic.
Report index
| # | Item | File | Tier | Images |
|---|---|---|---|---|
| 1 | PT-141 (Bremelanotide) | pt-141-bremelanotide | Tier 1 | 6/8 |
| 2 | Kisspeptin-10 | kisspeptin-10 | Tier 2 | 6/8 |
| 3 | Melanotan I (Afamelanotide) | melanotan-i | Tier 3 | 4/8 |
| 4 | Melanotan II | melanotan-ii | Tier 2 | 3/8 |
| 5 | Melanotan II nasal spray | melanotan-ii-nasal-spray | Tier 3 | 3/8 |
| 6 | Oxytocin | oxytocin | Tier 2 | 4/8 |
| 7 | Desmopressin | desmopressin | Tier 3 | 6/8 |
| 8 | DSIP | dsip | Tier 3 (weak) | 4/8 |
| 9 | Gonadorelin | gonadorelin | Tier 3 | 4/8 |
| 10 | Triptorelin | triptorelin | Tier 3 | 4/8 |
| 11 | Epithalon | epithalon | Tier 3 | 7/8 |
| 12 | Pinealon | pinealon | Tier 3 | 5/8 |
| 13 | HCG | hcg | Tier 2 | 5/8 |
Totals: 13 items · 14 Markdown files (13 items + this comparison) · 61 real images (zero AI-generated) · all prices dated 2026-09-20 · every file ends with the required "Not medical advice" notice.
Not medical advice. This is research documentation only. None of the grey-market research products in this track are approved for human use. Consult a licensed healthcare provider.
Named sources
- Facebook group: Peptides – information. Education. and sharing — 1,000
- Facebook group: Peptide Community 101 — 878
- Facebook group: Biohacking, Longevity, CRISPR, Supplements, Life Extension, Wim Hof — 10,000
- TRT – Testosterone Replacement Therapy – Wellness Group! — 1,000
- Facebook group: TanToday Discussion Board and Information — 2,000
- Facebook group: Tanning tips and facts — 4,000
- PT-141 Facebook-group dosing thread — Over50BodybuildingFitness, July 2026 (July 2026)
- Facebook group: HCG ExcelMale fertility threads — multi-year
- MT-II Instagram debate — Saladino/Idriss, June 2026 (June 2026)
Source URLs were not recorded for these references.